Large Meta-Analysis Quantifies Risk Of NSAIDs And Coxibs

Findings from a very large meta-analysis of clinical trials of NSAIDs may now allow physicians to quantify the cardiovascular and gastrointestinal risks associated with these drugs. The results of the Coxib and traditional NSAID Trialists’ (CNT) Collaboration, employing data from more than 350,000 randomized patients, have now been published in the Lancet.

Here are some of the key findings:

Click here to read the full post on Forbes.

English: Sintofarm

Leave a Reply

%d bloggers like this: